Table 2.
Outcomes of local and systemic tumor control at the last follow-ups.
| Local recurrences | New bone metastases | New visceral metastases | |
|---|---|---|---|
| Surgery (n = 35) | |||
| TES# (n = 4) | 0 | 3 (75.0%) | 0 |
| Debulking surgery (n = 31) | 13 (41.9%) | 14 (45.2%) | 12 (38.7%) |
| P value | 0.140 | 0.279 | 0.169 |
| Radioactive iodine therapy (n = 35) | |||
| Yes (n = 25) | 7 (28.0%) | 12 (48.0%) | 6 (24.0%) |
| No (n = 10) | 6 (60.0%) | 5 (50.0%) | 6 (60.0%) |
| P value | 0.086 | 0.604 | 0.053 |
| Local radiotherapy in debulking group (n = 31) | |||
| Yes (n = 17) | 4 (23.5%) | 7 (41.2%) | 4 (23.5%) |
| No (n = 14) | 9 (64.3%) | 7 (50.0%) | 8 (57.1%) |
| P value | 0.022a | 0.623 | 0.056 |
a
P value less than 0.05 were considered statistically significant.
TES stands for total en-bloc spondylectomy.